PARIS, Feb 16 (Reuters) - French drugmaker Sanofi-Aventis has agreed to buy Genzyme Corp for $20.1 billion in cash, plus payments tied to the success of the company's drugs, the companies said on ...
BOSTON, Nov 16 (Reuters) - Genzyme Corp , which is struggling through the most trying period in its history, said on Monday U.S. regulators will not approve its drug to treat Pompe disease, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback